Es gab 50 kürzliche Insider-Transaktionen für Aquestive Therapeutics, Inc. (AQST), darunter 20 Käufe und 27 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $5.32M und die gesamten Insider-Verkäufe auf $3.16M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Toth A Ernest Jr, Boyd Peter E., Barber Daniel. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — AQST
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-10 |
Toth A Ernest Jr |
Chief Financial Officer |
Informierter Verkauf |
58,254 |
$4.17 |
$243.09K |
376,112 |
| 2026-03-10 |
Boyd Peter E. |
Chief People Officer |
Informierter Verkauf |
29,814 |
$4.17 |
$124.41K |
338,509 |
| 2026-03-10 |
Barber Daniel |
President and CEO |
Informierter Verkauf |
180,677 |
$4.17 |
$753.97K |
1,004,753 |
| 2026-03-10 |
Braender Lori J |
Chief Legal Officer |
Informierter Verkauf |
40,102 |
$4.17 |
$167.35K |
442,879 |
| 2026-03-10 |
Jung Cassie |
Chief Operating Officer |
Informierter Verkauf |
45,791 |
$4.17 |
$191.09K |
274,980 |
| 2026-03-10 |
Korczynski Sherry |
Chief Commercial Officer |
Informierter Verkauf |
15,741 |
$4.17 |
$65.69K |
241,117 |
| 2026-03-10 |
Cioffi Melina |
SVP, Regulatory Affairs |
Informierter Verkauf |
25,311 |
$4.17 |
$105.62K |
274,867 |
| 2026-03-09 |
Toth A Ernest Jr |
Chief Financial Officer |
RSU-Zuteilung |
70,000 |
$4.29 |
$300.3K |
70,000 |
| 2026-03-09 |
Boyd Peter E. |
Chief People Officer |
RSU-Zuteilung |
42,500 |
$4.29 |
$182.33K |
42,500 |
| 2026-03-09 |
Barber Daniel |
President and CEO |
RSU-Zuteilung |
523,000 |
$4.29 |
$2.24M |
523,000 |
| 2026-03-09 |
Braender Lori J |
Chief Legal Officer |
RSU-Zuteilung |
50,000 |
$4.29 |
$214.5K |
50,000 |
| 2026-03-09 |
Jung Cassie |
Chief Operating Officer |
RSU-Zuteilung |
42,500 |
$4.29 |
$182.33K |
42,500 |
| 2026-03-09 |
Korczynski Sherry |
Chief Commercial Officer |
RSU-Zuteilung |
42,500 |
$4.29 |
$182.33K |
42,500 |
| 2026-03-09 |
Cioffi Melina |
SVP, Regulatory Affairs |
RSU-Zuteilung |
75,000 |
$4.29 |
$321.75K |
75,000 |
| 2026-03-09 |
Davis Matthew W. |
Chief Development Officer |
RSU-Zuteilung |
50,000 |
$4.29 |
$214.5K |
50,000 |
| 2026-03-09 |
Greenhawt Matthew J. |
Chief Medical Officer |
RSU-Zuteilung |
50,000 |
$4.29 |
$214.5K |
50,000 |
| 2026-03-02 |
Greenhawt Matthew J. |
Chief Medical Officer |
Unbekannt |
- |
- |
- |
2,000 |
| 2025-12-04 |
Boyd Peter E. |
Chief People Officer |
RSU-Zuteilung |
20,000 |
- |
- |
288,323 |
| 2025-12-02 |
Cioffi Melina |
SVP, Regulatory Affairs |
RSU-Steuereinbehalt |
2,083 |
$5.93 |
$12.35K |
200,178 |
| 2025-11-10 |
Davis Matthew W. |
Chief Development Officer |
RSU-Zuteilung |
50,000 |
$5.58 |
$279K |
50,000 |
| 2025-11-03 |
Davis Matthew W. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-10-15 |
Boyd Peter E. |
See Remarks |
Informierter Verkauf |
10,000 |
$7.00 |
$70K |
268,323 |
| 2025-10-15 |
Kraus Carl N |
Chief Medical Officer |
Informierter Verkauf |
20,272 |
$7.00 |
$141.9K |
282,475 |
| 2025-10-15 |
Jung Cassie |
Chief Operating Officer |
Optionsausübung (Verkauf) |
25,000 |
$3.10 |
$77.57K |
- |
| 2025-09-26 |
Boyd Peter E. |
See Remarks |
Informierter Verkauf |
10,000 |
$6.30 |
$63K |
278,323 |
| 2025-09-26 |
Barber Daniel |
President and CEO |
Informierter Verkauf |
91,343 |
$6.03 |
$551.19K |
923,430 |
| 2025-09-19 |
Barber Daniel |
President and CEO |
Informierter Verkauf |
400 |
$6.00 |
$2.4K |
1,014,773 |
| 2025-09-05 |
Boyd Peter E. |
See Remarks |
Informierter Verkauf |
15,000 |
$5.30 |
$79.5K |
288,323 |
| 2025-09-04 |
Jung Cassie |
Chief Operating Officer |
Optionsausübung (Verkauf) |
25,000 |
$0.71 |
$17.66K |
- |
| 2025-08-14 |
Korczynski Sherry |
Chief Commercial Officer |
RSU-Zuteilung |
25,000 |
- |
- |
181,858 |
| 2025-08-09 |
Kraus Carl N |
Chief Medical Officer |
RSU-Steuereinbehalt |
10,819 |
$3.90 |
$42.19K |
302,747 |
| 2025-06-11 |
Morris Timothy E |
Director |
RSU-Zuteilung |
42,000 |
$3.41 |
$143.22K |
42,000 |
| 2025-06-11 |
Brown Gregory B |
Director |
RSU-Zuteilung |
42,000 |
$3.41 |
$143.22K |
42,000 |
| 2025-06-11 |
Cochran John |
Director |
RSU-Zuteilung |
42,000 |
$3.41 |
$143.22K |
42,000 |
| 2025-06-11 |
Taglietti Marco |
Director |
RSU-Zuteilung |
42,000 |
$3.41 |
$143.22K |
42,000 |
| 2025-06-11 |
Krop Julie |
Director |
RSU-Zuteilung |
42,000 |
$3.41 |
$143.22K |
42,000 |
| 2025-06-11 |
Jenkins Abigail L. |
Director |
RSU-Rückgabe |
42,000 |
$3.41 |
$143.22K |
42,000 |
| 2025-06-09 |
Korczynski Sherry |
SVP Sales and Marketing |
RSU-Steuereinbehalt |
2,714 |
$3.54 |
$9.61K |
156,858 |
| 2025-05-15 |
Cioffi Melina |
SVP, Regulatory Affairs |
RSU-Zuteilung |
20,000 |
- |
- |
202,261 |
| 2025-04-25 |
Cioffi Melina |
SVP Regulatory Affairs |
Unbekannt |
- |
- |
- |
182,261 |
| 2025-03-10 |
Jung Cassie |
Chief Operating Officer |
RSU-Steuereinbehalt |
2,182 |
$2.54 |
$5.54K |
295,526 |
| 2025-03-10 |
Wargacki Stephen |
Chief Science Officer |
RSU-Steuereinbehalt |
4,572 |
$2.54 |
$11.61K |
343,552 |
| 2025-03-09 |
Toth A Ernest Jr |
Chief Financial Officer |
RSU-Steuereinbehalt |
8,736 |
$2.65 |
$23.15K |
339,366 |
| 2025-03-09 |
Boyd Peter E. |
See Remark |
RSU-Steuereinbehalt |
7,681 |
$2.65 |
$20.35K |
303,323 |
| 2025-03-09 |
Barber Daniel |
President and CEO |
RSU-Steuereinbehalt |
53,998 |
$2.65 |
$143.09K |
1,015,173 |
| 2025-03-09 |
Braender Lori J |
Chief Legal Officer |
RSU-Steuereinbehalt |
10,658 |
$2.65 |
$28.24K |
402,981 |
| 2025-03-09 |
Jung Cassie |
Chief Operating Officer |
RSU-Steuereinbehalt |
7,997 |
$2.65 |
$21.19K |
297,708 |
| 2025-03-09 |
Wargacki Stephen |
Chief Science Officer |
RSU-Steuereinbehalt |
15,431 |
$2.65 |
$40.89K |
348,124 |
| 2025-03-07 |
Toth A Ernest Jr |
Chief Financial Officer |
RSU-Zuteilung |
60,000 |
$2.65 |
$159K |
60,000 |
| 2025-03-07 |
Boyd Peter E. |
See Remark |
RSU-Zuteilung |
40,000 |
$2.65 |
$106K |
40,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
